亿帆医药：全资子公司收到易黄汤颗粒药品注册受理通知书

Core Viewpoint - Yifan Pharmaceutical's wholly-owned subsidiary, Suzhou Yifan Pharmaceutical Co., Ltd., has received the acceptance notice for the registration and marketing application of Yihuang Decoction Granules from the National Medical Products Administration, marking a significant step in the company's product development [1] Group 1 - The Yihuang Decoction Granules is the first classic prescription product registered by the company, aimed at treating kidney deficiency with damp-heat symptoms [1] - The product is indicated for functions such as kidney strengthening and dampness elimination, specifically for conditions related to kidney deficiency and damp-heat [1] - As of the date of this report, there are no other products on the domestic market that are derived from the same prescription as Yihuang Decoction Granules [1]